8-K: IR-MED's PressureSafe Device Initiates Usability Study at Methodist Healthcare

IR-MED's PressureSafe device, designed for early detection of pressure injuries, has commenced a usability study at Methodist Healthcare in San Antonio, Texas.

Summary

• IR-MED, Inc. has begun a usability study for its PressureSafe device at Methodist Healthcare.
• The study aims to evaluate the device's effectiveness in early detection of pressure injuries across various skin tones.
• PressureSafe uses infrared light and AI to detect biomarkers beneath the skin's surface.
• A previous study in Israel showed PressureSafe had a 92% efficacy in detecting pressure injuries and reduced their incidence by 50%.
• Pressure injuries cost the US healthcare system $26.8 billion annually and result in 60,000 deaths each year.
• The study will enroll up to 104 participants, with approximately half having dark skin tones.
• The device is designed to address healthcare inequality, as people with dark skin tones are more than twice as likely to suffer from pressure injuries.

Sentiment

Score: 8

Explanation: The document presents a positive development with the start of a usability study at a reputable healthcare provider, building on promising results from a previous study. The technology addresses a significant healthcare need and has the potential to reduce costs and improve patient outcomes. However, there are still risks associated with the development and commercialization of the device.

Positives

• The PressureSafe device has shown promising results in a previous study, with 92% efficacy in detecting pressure injuries.
• The device is designed to be skin-color agnostic, addressing a significant healthcare disparity.
• The usability study at Methodist Healthcare is a major milestone for IR-MED.
• The device has the potential to reduce healthcare costs associated with pressure injuries.
• The technology is non-invasive, which is beneficial for patient comfort and safety.

Negatives

• The study is still in the usability phase, and the results are not yet conclusive.
• The device's effectiveness in a real-world setting needs to be validated.
• The company is reliant on the success of this study and future studies for commercialization.

Risks

• The company's future performance is subject to many factors, including the ability to raise capital.
• The success of the device depends on the results of clinical studies and trials.
• There are risks associated with FDA approval/clearance of the product.
• The company faces competition from other medical device manufacturers.
• Product liability or other adverse litigation could impact the company.

Future Outlook

IR-MED is optimistic about the potential of PressureSafe to significantly contribute to healthcare by reducing the risk and severity of pressure injuries, but the company's future performance is subject to various risks and uncertainties.

Management Comments

• Mary Lee Potter, PhD, MBA, RN, CWOCN, stated that the study is important for improving patient outcomes.
• Dr. Yaniv Cohen, IR-MED's Co-Founder and Chief Science Officer, expressed pleasure in partnering with Methodist Healthcare and hopes to demonstrate that PressureSafe can support nursing staff, improve patient outcomes, and reduce healthcare costs.

Industry Context

This announcement highlights the growing focus on innovative medical devices that use AI and non-invasive technologies to improve patient care and reduce healthcare costs. The emphasis on addressing healthcare disparities, particularly in the detection of pressure injuries in people with dark skin tones, is also a significant trend in the industry.

Comparison to Industry Standards

• The 92% sensitivity and 88% specificity achieved in the previous study at Clalit hospitals in Israel is a strong result compared to traditional visual inspection methods.
• The 50% reduction in pressure injury incidence in the previous study is a significant improvement compared to industry averages.
• The focus on skin-color agnostic technology addresses a known gap in current pressure injury detection methods, which often underperform in individuals with darker skin tones.
• The study at Methodist Healthcare, a respected healthcare provider, provides a strong validation point for the technology.

Stakeholder Impact

• Shareholders may see a positive impact if the study is successful and the device is commercialized.
• Employees may benefit from the growth and success of the company.
• Patients may benefit from improved early detection and prevention of pressure injuries.
• Healthcare providers may benefit from a more accurate and efficient tool for pressure injury detection.
• Payers may benefit from reduced healthcare costs associated with pressure injuries.

Next Steps

• The usability study at Methodist Healthcare will continue with patient enrollment and monitoring.
• The study will assess the sensitivity and specificity of PressureSafe compared to standard visual skin assessment.
• IR-MED will analyze the results of the study to further refine the device and prepare for potential commercialization.

Key Dates

Keywords

PressureSafe, pressure injuries, medical device, usability study, infrared spectroscopy, artificial intelligence, healthcare, skin tone, non-invasive, biomarkers